Altered nutrition state in the severe multiple trauma patients undergoing adjuvant recombinant human growth hormone nutritional support therapy

Abstract

In order to observe the nutrition state in the severe multiple trauma patients undergoing adjuvant recombinant human growth hormone (rhGH) nutritional support therapy, 45 patients with severe multiple traumas (ISS>25) were randomly divided into 3 groups. All the 3 groups had been supplied with nitrogen and caloricity according to the need of patients for 16 days. The rhGH therapy started 48 h after surgery and lasted for 14 days in two rhGH-treated groups in which rhGH was 0.2 and 0.4 U/(kg · d) respectively, and the resting group served as control one. The levels of nitrogen balance, prealbumin and safety variables (blood sugar, Na⁺, TT₃ and TT₄) were observed and compared among the three groups. The levels of nitrogen balance on the postoperative day (POD) 3 and 5 in the rhGH-treated groups were −1.28±3.19, 5.45±2.00 and −0.18±2.55, 6.11±1.60, respectively, which were significantly higher than those in the control group (−5.17±1.68 and −1.08±3.31, P<0.01). The values of prealbumin on the POD 3 and 5 in the rhGH-treated groups were 180.19±27.15, 194.44±50.82 and 194.94±29.65, 194.11±16.17, respectively, which were significantly higher than those in the control group (117.42±19.10 and 135.63±28.31, P<0.01). There was no significant difference between the rhGH 0.2 U/(kg · d) group and rhGH 0.4 U/(kg · d) group in both of the levels of nitrogen balance and prealbumin. It is concluded that the nutritional support therapy with adjuvant rhGH which starts 48 h after surgery improves the nutrition state of the patients with severe multiple trauma. It is safe for severe multiple trauma patients who accept rhGH at the dose of 0.2 and 0.4 U/(kg · d).

Keywords

recombinant human growth hormone / nutritional support / severe multiple trauma / nitrogen balance / prealbumin

References

[1] PlankL. D., ConnolyA. B., HillG. L., et al.. Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis. Ann Surg, 1998, 228(2): 146-150

[2] ShawJ. H. F., WolfeR. R.. Metabolic intervention in surgical patients: an assessment of the effect of somatostatin, ranitidine, naloxone, diclophenac, dipyridamole, or salbutamol infusion on energy and protein kinetics in surgical patients using stable and radioisotopes. Ann Surg, 1988, 207: 274-282

[3] JacobsD. G., JacobsD. O., KudskK. A., et al.. Practice management guidelines for nutritional support of the trauma patient. J Trauma, 2004, 57(3): 660-679

[4] StechmillerJ. K., TreloarD., Allen-N, et al.. Gut dysfunction in critically ill patients: a review of the literature. Am J Crit Care, 1997, 6: 204-209

[5] BengtssonB. A., EdenS., LonnL., et al.. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab, 1993, 76: 309-317

[6] ShimodaN., TashiroT., YamamoriH., et al.. Effects of growth hormone and insulin-like growth factor I on metabolism, gutmorphology, and cell-mediated immunity in burned rats. Nutrition, 1997, 13(6): 540-546

[7] HerndonD. N., HawkinsH. K., NguyenT. T.. Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg, 1995, 221(6): 649-656

[8] PrietoI., Gomez de SeguraI. A., Garcia GrandeA., et al.. Growth hormone reduces bacterial translocation in radiation enteritis rat. Rev Esp Enferm Dig, 1998, 90(5): 353-360

[9] YuK. J., ZhaoM. Y., GaoM. S., et al.. Contribution of Recombinant Human Growth Hormone in the Respiratory Failare Treatment. Neu I Med J China, 2001, 81(18): 1135-1136

[10] VaraT. R., GuerreroJ. A., RuizR. E., et al.. Can the use of growth hormone reduce the postoperative fatigue syndrome?. World J Surg, 1996, 20: 81-86

[11] JeevanandamM., RamiasL., ShamosR. F., et al.. Decreased growth hormone levels in the catabolic phase of severe injury. Surgery, 1992, 111(5): 495-502

[12] LundebergS., BelfrageM., WemermanJ., et al.. Growth hormone improves muscle protein metabolism and whole body nitrogen economy in man during a hyponitrogenous diet. Metabolism, 1994, 40: 315-322

[13] KarlJ. Q., RainerD.. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med, 2000, 342: 134-136